Immucell Corp (ICCC) Reports Q1 EPS of $0.11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ImmuCell Announces First Quarter 2016 Financial Results
May 11, 2016 4:17 PM EDTPORTLAND, ME -- (Marketwired) -- 05/11/16 -- ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial results for its first quarter ended March 31, 2016.
"First quarter 2016 sales of $3 million were very strong, coming within $115,000 of the all-time high sales mark of $3.1 million set during the first quarter of 2015," commented Michael F. Brigham, President and CEO of ImmuCell. "We ended the just completed quarter with a backlog of orders... More
